cbdMD, Inc. (YCBD) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 2 Buy, 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-21.04 and revenue of $0.02B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.79 vs est $-21.04 (beat +91.5%). 2025: actual $-1.09 vs est $-1.08 (missed -0.9%). Analyst accuracy: 0%.
YCBD Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to cbdMD, Inc. in the past 3 months
EPS Estimates — YCBD
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.79
vs Est –$21.04
▲ 1,075.4% off
2025
Actual –$1.09
vs Est –$1.08
▼ 0.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — YCBD
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.019B
vs Est $0.020B
▼ 1.3% off
2025
Actual $0.019B
vs Est $0.019B
▲ 0.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
